Roivant Sciences Ltd (ROIV)
Return on equity (ROE)
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -171,981 | -116,621 | 4,810,178 | 4,736,035 | 4,348,922 | 4,466,420 | -981,774 | -993,368 | -1,055,336 | -1,313,032 | -1,245,554 | -1,138,114 | -866,513 | -1,084,764 | -1,061,257 | -888,174 | -809,234 | -299,670 |
| Total stockholders’ equity | US$ in thousands | 4,687,600 | 5,189,470 | 5,580,040 | 5,435,310 | 5,968,580 | 6,089,760 | 948,534 | 910,730 | 1,157,770 | 955,520 | 1,160,600 | 1,384,110 | 2,038,940 | 2,247,260 | 2,038,020 | 1,723,120 | 1,797,790 | — |
| ROE | -3.67% | -2.25% | 86.20% | 87.13% | 72.86% | 73.34% | -103.50% | -109.07% | -91.15% | -137.42% | -107.32% | -82.23% | -42.50% | -48.27% | -52.07% | -51.54% | -45.01% | — |
March 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-171,981K ÷ $4,687,600K
= -3.67%
Roivant Sciences Ltd's return on equity (ROE) witnessed significant fluctuations over the past few years. The company's ROE was negative from December 2020 to June 2024, indicating that the company was not generating satisfactory returns for its shareholders relative to its equity base during this period. The ROE reached its lowest point in September 2022 at -137.42%.
However, there was a notable turnaround in the company's performance starting from December 2024, with ROE turning positive and showing improvement in subsequent quarters. In December 2024, ROE was -2.25%, and it gradually increased to -3.67% by March 2025.
The sudden positive change in ROE from negative values to positive values starting in December 2024 suggests that the company may have implemented strategic initiatives to enhance profitability and efficiency. It is important for investors to monitor Roivant Sciences Ltd's ROE trend to assess the company's ability to generate returns on the equity invested by shareholders.
Peer comparison
Mar 31, 2025